Expression of the costimulator molecules, CD40 and CD154, on lymphocytes from neonates and young children

Human Immunology

Volumn 61, Issue 4, 2000, Pages 378-388

  Elliott, Salenna R ^a,b   Roberton, Don M ^b   Zola, Heddy ^a   MacArdle, Peter J ^c  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

CD154; CD40; Human; Lymphocytes; Neonate

Indexed keywords

CD40 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOSTIMULATION; INFANT; LYMPHOCYTE; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD40; ANTIGENS, CD45; B-LYMPHOCYTE SUBSETS; CD40 LIGAND; FETAL BLOOD; HUMANS; INFANT; INFANT, NEWBORN; INTERPHASE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTE SUBSETS; TIME FACTORS;

EID: 0034105055     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00189-5     Document Type: Article

References (40)

1. Andersson U., Bird A.G., Britton B.S., Palacios R. Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev. 57:1981;1.
2. Durandy A., Thuillier L., Forveille M., Fischer A. Phenotypic and functional characteristics of human newborns' B lymphocytes. J Immunol. 144:(1):1990;60.
3. Gathings W.E., Kubagawa H., Cooper M.D. A distinctive pattern of B cell immaturity in perinatal humans. Immunol Rev. 57:1981;107.
4. Hayward A., Cosyns M. Proliferative and cytokine responses by human newborn T cells stimulated with staphylococcal enterotoxin B. Pediatr Res. 35:(3):1994;293.
5. Miyawaki T., Moriya N., Nagaoki T., Taniguchi N. Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood. Immunol Rev. 57:1981;61.
6. Splawski J.B., Jelinek D.F., Lipsky P.E. Delineation of the functional capacity of human neonatal lymphocytes. J Clin Invest. 87:(2):1991;545.
7. Splawski J.B., Lipsky P.E. Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes. J Clin Invest. 88:(3):1991;967.
8. Tosato G., Magrath I.T., Koski I.R., Dooley N.J., Blaese R.M. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes. J Clin Invest. 66:(2):1980;383.
9. Di Sant'Agnese P.A. Simultaneous immunization of newborn infants against diphtheria, tetanus and pertussis. Am J Public Health. 40:1950;674.
10. Ridings J., Nicholson I.C., Goldsworthy W., Haslam R., Roberton D.M., Zola H. Somatic hypermutation of immunoglobulin genes in human neonates. Clin Exp Immunol. 108:1997;366.
11. Zola H. The development of antibody responses in the infant. Immunol Cell Biol. 75:1997;587.
12. Callard R.E., Armitage R.J., Fanslow W.C., Spriggs M.K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today. 14:(11):1993;559.
13. Splawski J.B., Fu S.M., Lipsky P.E. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol. 150:(4):1993;1276.
14. Gray D., Siepmann K., Wohlleben G. CD40 ligation in B cell activation, isotype switching and memory development. Semin Immunol. 6:(5):1994;303.
15. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu Rev Immunol. 12:1994;881.
16. Gray D., Siepmann K., van Essen D., Poudrier J., Wykes M., Jainandunsing S., Bergthorsdottir S., Dullforce P. B-T lymphocyte interactions in the generation and survival of memory cells. Immunol Rev. 150:1996;45.
17. Foy T.M., Laman J.D., Ledbetter J.A., Aruffo A., Claassen E., Noelle R.J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med. 180:(1):1994;157.
18. Durandy A., De Saint Basile G., Lisowska Grospierre B., Gauchat J.F., Forveille M., Kroczek R.A., Bonnefoy J.Y., Fischer A. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol. 154:(4):1995;1560.
19. Fuleihan R., Ahern D., Geha R.S. Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur J Immunol. 24:(8):1994;1925.
20. Nonoyama S., Penix L.A., Edwards C.P., Lewis D.B., Ito S., Aruffo A., Wilson C.B., Ochs H.D. Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest. 95:(1):1995;66.
21. Brugnoni D., Airo P., Graf D., Marconi M., Lebowitz M., Plebani A., Giliani S., Malacarne F., Cattaneo R., Ugazio A.G., et al. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol. 24:(8):1994;1919.
22. Splawski J.B., Nishioka J., Nishioka Y., Lipsky P.E. CD40 ligand is expressed and functional on activated neonatal T cells. J Immunol. 156:(1):1996;119.
23. Hermann P., Blanchard D., de Saint Vis B., Fossiez F., Gaillard C., Vanbervliet B., Briere F., Banchereau J., Galizzi J.P. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur J Immunol. 23:(4):1993;961.
24. van Kooten C., Gaillard C., Galizzi J.P., Hermann P., Fossiez F., Banchereau J., Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol. 24:(4):1994;787.
25. Yellin M.J., Sippel K., Inghirami G., Covey L.R., Lee J.J., Sinning J., Clark E.A., Chess L., Lederman S. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol. 152:(2):1994;598.
26. Ludewig B., Henn V., Schroder J.M., Graf D., Kroczek R.A. Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. Eur J Immunol. 26:(12):1996;3137.
27. Nusslein H.G., Frosch K.H., Woith W., Lane P., Kalden J.R., Manger B. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur J Immunol. 26:(4):1996;846.
28. Ledbetter J.A., Shu G., Gallagher M., Clark E.A. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J Immunol. 138:(3):1987;788.
29. Lederman S., Yellin M.J., Krichevsky A., Belko J., Lee J.J., Chess L. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med. 175:(4):1992;1091.
30. Rubin L.A., Kurman C.C., Biddison W.E., Goldman N.D., Nelson D.L. A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac. Hybridoma. 4:(2):1985;91.
31. Goding J.W. Monoclonal Antibodies Principles and Practice. Production and Application of Monoclonal Antibodies in Cell Biology, Biochemistry and Immunology. 1996;Academic Press, London.
32. Zola H., Neoh S.H., Mantzioris B.X., Webster J., Loughnan M.S. Detection by immunofluorescence of surface molecules present in low copy numbers. High sensitivity staining and calibration of flow cytometer. J Immunol Methods. 135:(1-2):1990;247.
33. Elliott S.R., Macardle P.J., Zola H. Removal of erythroid cells from umbilical cord blood mononuclear cell preparations using magnetic beads and a monoclonal antibody against glycophorin A. J Immunol Methods. 217:1998;121.
34. Julius M.H., Simpson E., Herzenberg L.A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 3:1973;645.
35. Hirohata S., Jelinek D.F., Lipsky P.E. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J Immunol. 140:(11):1988;3736.
36. Patel H.R., Oshiba A., Jeppson J.D., Gelfand E.W. Differential expression of CD40 ligand on T cell subsets. Implications for different roles of CD45RA+ and CD45RO+ cells in IgE production. J Immunol. 156:(5):1996;1781.
37. Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol. 22:(10):1992;2573.
38. Casamayor Palleja M., Khan M., MacLennan I.C. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med. 181:(4):1995;1293.
39. Miyashita T., McIlraith M.J., Grammer A.C., Miura Y., Attrep J.F., Shimaoka Y., Lipsky P.E. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions. J Immunol. 158:(10):1997;4620.
40. Akbar A.N., Terry L., Timms A., Beverley P.C., Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol. 140:(7):1988;2171.